4D pharma Announces Publication of Preclinical Research Showing Single Strain Megasphaera massiliensis improves activity of CAR-T
4d Pharma PLC (DDDD.L) Conference presentation on LBP Manufacturing
4D pharma to Present at the Microbiome Movement Drug Development Summit
4d Pharma PLC (DDDD.L) Asthma trial Part A enrollment and program update
4D pharma Completes Enrollment of Part A of the Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma and Provides Program Update
Verona Pharma plc (LON:VRP) Positive Top-line Data in 4 Week Phase 2b COPD Study.
Primary endpoint met at all doses: ensifentrine produced clinically and statistically significant dose-dependent improvements in lung function